Comment: Barbiturates could enhance adverse outcomes, such as respiratory depression, produced by toxic doses of TCAs. With therapeutic doses of TCAs, barbiturates raise metabolism and decrease blood concentrations of TCAs.Watch Carefully (1)phenobarbital will reduce the level or effect of tofacitinib by affecting hepatic/intestinal enzyme CYP3A4 m